| Also known as |
Domperidone Maleate |
| Blood pressure |
Does not typically affect blood pressure |
| Chemical name |
5-Chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidyl]-1,3-dihydro-2H-benzimidazol-2-one |
| Dosage (medical) |
10 mg three to four times daily before meals and at bedtime |
| Dosage (sports) |
Not applicable |
| Effects |
Enhances gastrointestinal motility, increases lower esophageal sphincter pressure, facilitates gastric emptying |
| Formula |
C22H24ClN5O2 |
| Half-life |
7 to 9 hours |
| Hepatotoxicity |
Rare, but cases of serious liver injury have been reported |
| Lab Test |
Not typically monitored via lab tests in clinical settings |
| Main action |
Antiemetic and gastroprokinetic agent |
| Side effects |
Dry mouth, abdominal cramps, dizziness, headache, somnolence |
| Storage conditions |
Store at room temperature, protect from light |
| Strength |
10 mg |
| Substance class |
Dopamine antagonist |
| Trade name |
Motilium, among others |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant water retention |
| Manufacturer |
Cipla |
